Grant ID PP180091
Awarded On August 24, 2018
Title STOP-HCC Expansion Grant
Program Prevention
Award Mechanism Expansion of Cancer Prevention Services to Rural and Medically Underserved Populations
Institution/Organization The University of Texas Southwestern Medical Center
Principal Investigator/Program Director Mamta Jain
Cancer Sites Gallbladder, Liver and Intrahepatic Bile Duct
Contracted Amount $2,592,731
Lay Summary

Hepatocellular cancer (HCC) is the fastest growing cancer in Texas. The age-adjusted incidence of liver cancer in Texas is the highest in the U.S. The majority of HCC is due to viral hepatitis, primarily hepatitis C (HCV) in the US and hepatitis B virus (HBV) globally. HCV is curable and HBV is a vaccine-preventable disease. To reduce HCC burden, we are targeting counties in North, South and West Texas with high HCC incidence and significant need to increase prevention through HCV and HBV screening, immunization, and treatment.

A robust primary care-based HCV screening program for baby boomers (BBs; born 1945-65) and HBV/HCV case finding other high risk groups based on national and exp...

Read More